remdesivir | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
February 09, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, FEBRUARY 09, 2023

remdesivir

antiviral drug Remdesivir. Photo : BSS/AFP
Coronavirus chronicle

Gilead's remdesivir reduces Covid-19 mortality risk

The drugmaker said on Monday it analyzed data from 98,654 patients from three retrospective studies of the real-world treatment of hospitalised Covid-19 patients.

Photo: Collected
Coronavirus chronicle

Man arrested in Ahmedabad with Remdesivir vials for sale in Bangladesh

Harsh Vardhan Shringla
South Asia

India to receive medical support from more than 40 countries, including Bangladesh

Bangladesh to send Remdesivir to India next week
Coronavirus chronicle

Bangladesh to send Remdesivir to India next week

Photo :Times of India
Coronavirus chronicle

India approaches Bangladesh and other countries for Remdisivir

FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/File Photo/File Photo
Coronavirus chronicle

Gilead to help India boost remdesivir production, promises at least 450,000 vials

Photo: Collected
Coronavirus chronicle

India seeks remdesivir, oxygen from EU, aid expected soon - EU official

Photo: Collected.
Coronavirus chronicle

Remdesivir has side effects too, warns expert as demand rises in Covid 2nd wave

Photo: Collected
Coronavirus chronicle

India clarifies on Remdesivir, says it is ‘not life-saving drug’

antiviral drug Remdesivir. Photo : BSS/AFP
Covid-19 in Bangladesh

Embattled Indian state looks to Bangladesh pharmas for supplies of Remdesivir

Photo: Collected
Coronavirus chronicle

India bans exports of anti-viral drug Remdesivir as Covid-19 cases surge

Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?
Covid-19 in Bangladesh

Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

Photo: Collected
Coronavirus chronicle

EU drugs regulator studying expanded use of Covid-19 drug remdesivir

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]